Lunai Bioworks revenue LNAI
Sales by quarter and over the last twelve months, from 2013.
- Last 12 months, to Mar 31, 2026
- n/m
- a quarter missing
- Latest quarter, Q3 FY26
- $20.9K
- Fiscal year 2016
- n/a
Lunai Bioworks' twelve-month revenue can't be added up yet: a quarter of its results is missing from our data.
In its latest quarter, Q3 FY26, it was $20.9K.
Revenue over time
Fiscal year by fiscal year
| Fiscal year | Revenue | Change |
|---|---|---|
| FY2016 | n/a | n/a |
| FY2013 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | Revenue | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q3 FY26 | $20.9K | n/a | n/a | |
| Q4 FY16 | $244 | n/a | n/a | |
| Q3 FY16 | $0 | n/a | n/a | |
| Q2 FY16 | $42.5K | n/a | n/a | |
| Q3 FY14 | $285 | n/a | $32.8K | |
| Q2 FY14 | $925 | n/a | n/a | |
| Q1 FY14 | $0 | n/a | n/a | |
| Q4 FY13 | $31.6K | n/a | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Lunai Bioworks' size, closest first, today.
| Company | Revenue, 12 months | Growth |
|---|---|---|
| LNAILunai Bioworks | n/m | |
| NXTSNexentis Technologies | n/m | |
| DCOYDecoy Therapeutics | n/m | |
| ARTLArtelo Biosciences | n/m | |
| GOVXGeoVax Labs | $0 | −100% a year |
| MTNBMatinas BioPharma | n/m | |
| SBFMSunshine Biopharma | $35.3M | −3% a year |
| VBIOValion Bio | n/m | |
| LABTLakewood-Amedex Biotherapeutics | n/m | |
| KAPAKairos Pharma, LTD. | n/m | |
| OGENOragenics | n/m | |
| Peer median | $17.7M |
What the revenue tells you
Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.
Growing revenue with shrinking margins is a warning, not a win.
More on Lunai Bioworks
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.